Showing results (181-190 of 266) with videos related to

Sort By:
Pageof 27
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
International Journal of Molecular Sciences|December 28, 2016
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer ProgressionAnne von Mässenhausen, Johannes Brägelmann, Hannah Billig, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Tumor rejection in <i>Cblb</i><sup>-/-</sup> mice depends on IL-9 and Th9 cellsOliver Schanz, Isabelle Cornez, Sowmya Parampalli Yajnanarayana, et al.
Oncotarget|September 9, 2017
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinomaTim Müller, Martin Braun, Dimo Dietrich, et al.
Patterns (New York, N.Y.)|October 25, 2021
Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasmsNanditha Mallesh, Max Zhao, Lisa Meintker, et al.
Cancer Immunology, Immunotherapy : CII|November 28, 2012
Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptidesStefanie Andrea Erika Held, Katharina Maria Duchardt, Stefan Tenzer, et al.
Cancer Immunology, Immunotherapy : CII|December 22, 2009
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linkedMarie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, et al.
Pediatric Radiology|January 26, 2018
Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma stagingMonika Scheer, Tobias Dantonello, Peter Brossart, et al.
Pageof 27